Serum Protein Patterns in Participants With Mycosis Fungoides/Cutaneous T-Cell Lymphoma, Psoriasis, or Normal Skin
Completed · Not applicable
Conditions studied: Lymphoma
In brief
RATIONALE: The presence of specific serum proteins may allow a doctor to determine if a patient has mycosis fungoides/cutaneous T-cell lymphoma. PURPOSE: This clinical trial is studying how well blood protein analysis detects mycosis fungoides/cutaneous T-cell lymphoma.
Key facts
- Study ID
- NCT00066664
- Run by
- National Institutes of Health Clinical Center (CC)
- People needed
- 423
- Starts
- 2003-06-01
- Expected to finish
- 2010-03-01
- Last updated by the study team
- 2012-03-15
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.
Where it is running
- Stanford Cancer Center — Stanford, California, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland, United States
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office — Bethesda, Maryland, United States
- University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.